Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma
Clinical trial NCT04267146 · COMPLETED
Trial details
- NCT number
- NCT04267146
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2024-11-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.